Celltrion, Stock Price +0.59% at This Time... 401,646 Shares Net Bought by Individuals in the Last 5 Days

As of 12:30 PM on the 16th, Celltrion is trading at 256,500 KRW, up 0.59% from the previous day. The trading volume is 304,808 shares, which is 50.71% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On October 15, Hana Financial Investment researchers Sun Min-jung and Kang Seung-won stated, "The top-line high growth of Celltrion in 2020 was already anticipated. The approval timing for the Humira biosimilar, for which the application was submitted to the European EMA in March this year, is expected in the second quarter of next year, with production likely to start within this year. Since the number and volume of products to be produced will increase, steady capacity expansion and securing capacity are essential for Celltrion. With annual new product launches and consistent capacity expansion, Celltrion's sales are expected to sustain continuous growth in the mid to long term." They set Celltrion's target price at 363,000 KRW.

Over the past five days, individual investors have net purchased 401,646 shares of Celltrion, while foreigners and institutions have net sold 319,000 shares and 94,910 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.